Clinical Trial Update: Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating recombinant anti-TNF-alpha antibodies for rheumatoid arthritis; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Recombinant anti-TNF-alpha antibodies

Snippet

Sponsor: Genor Biopharma Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN